TheEdgeResearch
Home / Stocks / RVVQF

RavenQuest BioMed Inc. (RVVQF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$1,236
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
5.69
52-Wk Range
0.000001-0.000189
CEO
David Allen Cross
Country
CA
Currency
USD

RavenQuest BioMed Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,236. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -2423.9%. Its beta of 5.69 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-0.47
Gross margin
63.7%
Operating margin
-1366.4%
Net margin
-2423.9%
Return on equity
—
Debt / equity
0.59
Current ratio
1.14
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2018-03-05
Headquarters
Vancouver, BC, CA
About RavenQuest BioMed Inc.

RavenQuest BioMed Inc. operates primarily within the cannabis industry. Its core activities include the cultivation of cannabis, offering management and consulting solutions, and conducting specialized research and development. The company structures its operations into two distinct areas: a consulting division and a segment dedicated to the growth and sale of medical cannabis. Its products are available under the brand names Lore Cannabis and Bloomera. The entity, originally known as Ravencrest Resources Inc., rebranded to RavenQuest BioMed Inc. in September 2017. Founded in 1987, its corporate headquarters are situated in Vancouver, Canada.

Comparable companies

RavenQuest BioMed Inc. is most often compared with the following Healthcare names:

AVTBFBBRRFCANNCPIVFMVMDFPCLOFRPNRFSEHCFTHCBFVDQSF
More research on RVVQF
RVVQF technical analysis RVVQF TheEdge Score Compare against peers
Open full interactive analysis & DCF →